Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension

Biological Trace Element Research

Volumn 107, Issue 1, 2005, Pages 21-32

  Kȩdzierska, Karolina ^a   Bober, Joanna ^a   Ciechanowski, Kazimierz ^a   Gołembiewska, Edyta ^a   Kwiatkowska, Ewa ^a   Noceń, Iwona ^a   Dołȩgowska, Barbara ^a   Dutkiewicz, Grazyna ^a   Chlubek, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cellular membrane; Copper; Erythrocyte; Hypertension; Na H exchange; Na K ATP ase; Sodium transporting systems

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLORIDE; COPPER; LITHIUM; POTASSIUM ION; SODIUM; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ESSENTIAL HYPERTENSION; HUMAN; MALE; SODIUM TRANSPORT;

CHLORIDES; COPPER; ERYTHROCYTE MEMBRANE; HUMANS; HYPERTENSION; LITHIUM; MALE; NA(+)-K(+)-EXCHANGING ATPASE; POTASSIUM; REGRESSION ANALYSIS; SODIUM; SODIUM-HYDROGEN ANTIPORTER; SPECTROPHOTOMETRY, ATOMIC;

EID: 24944449455     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. R. Lijnen, Alterations in sodium metabolism as an etiological model for hypertension, Cardiovasc. Drugs Ther. 9, 377-399 (1995).
2. + exchange in patients with essential hypertension, Am. J. Hypertens. 2, 903-908 (1989).
3. + countertransport activity in essential hypertensive patients, Eur. J. Clin. Invest. 26, 64-70 (1996).
4. A. Alonso, A. Arrazola, A. Garciandia, N. Esparza, C. Gomez-Alamillo, and C. Diez, Erythrocyte anion exchanger activity and intracellular pH in essential hypertension, Hypertension 22, 348-356 (1993).
5. J. Bober, K. Kȩdzierska, E. Kwiatkowska, et al., The erythrocyte sodium-proton exchanger activity in patients with primary hypertension, Pol. Arch. Med. Wewn. 1, 619-624 (2002).
6. + exchangers in health and disease processes, J. Invest. Med. 43, 419-430 (1995).
7. + exchanger is stimulated and cell volume increased in lymphocytes from patients with essential hypertension, J. Hypertens. 9, 519-524 (1991).
8. M. Canessa, K. Morgan, R. Goldszer, T. J. Moore, and A. Spalvins, Kinetics abnormalities of the red blood cell sodium-proton exchange in hypertensive patients, Hypertension 17, 340-348 (1991).
9. O. Giampietro, E. Matteucci, G. Catapano, et al., Microalbuminuria and erythrocyte sodium-hydrogen exchange in essential hypertension, Hypertension 25, 981-985 (1995).
10. A. de la Sierra, A. Coca, J. C. Pare, M. Sanchez, V. Valls, and A. Urbano-Marquez, Erythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy, Circulation 88, 1628-1633 (1993).
11. J. Zicha, Red cell ion transport abnormalities in experimental hypertension, Fundam. Clin. Pharmacol. 7, 129-141 (1993).
12. H. E. Ives, Ion transport defects and hypertension. Where is the link? Hypertension 14, 590-597 (1989).
13. + exchange inhibitors: potential mechanisms of action, Basic Res. Cardiol. 96, 306-311 (2001).
14. M. Karmazyn, Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target, Basic Res. Cardiol. 96, 325-328 (2001).
15. + antiport activity and left ventricular nyocardial function in type I insulin-dependent diabetes mellitus, J. Diabetes Complic. 9, 208-211 (1995).
16. M. Toborek, T. Wasik, M. Drozdz, M. Klin, K. Magner-Wrobel, and E. Kopieczna Grzebieniak, Effect of hemodialysis on lipid peroxidation and antioxidatant sysytem in patients with chronic renal failure, Metabolism 41, 1229-1232 (1992).
17. M. Cutaia and N. Parks, Oxidant stress decreased Na+/H+ antiport activity in bovine pulmonary artery endothelial cells, Am. J. Physiol. 267, L649-L659 (1994).
18. + exchange, Circ. Res. 83, 644-651 (1998).
19. E. Matteucci and O. Giampietro. Oxidative stress in families of type 1 diabetic patients, Diabet. Care. 24, 167-168 (2001).
20. A. Y. Bogdanova, L. V. Virkki, G. P. Gusev, and M. Nikinmaa, Copper effects on ion transport across lamprey erythrocyte membrane: Cl(-)/OH(-) exchange induced by cuprous ions, Toxicol. Appl. Pharmacol. 159, 204-131 (1999).
21. A. Y. Bogdanova, M. Gassman, and M. Nikinmaa, Copper ion redox state is critical for its effects on ion transport pathways and methaemoglobin formation in trout erythrocyte, Chem. Biol. Ineract. 139, 43-59 (2002).
22. I. Hajjar and T. Kotchen, Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data, J. Nutr. 133, 211-214 (2003).
23. M. D. Chen and W. H. Sheu, Plasma status of selected minerals in hypertensive men with and without insulin resistance, J. Trace Elements Med. Biol. 14, 228-231 (2001).
24. C. Russo, O. Olivieri, D. Girelli, et al., Anti-oxidant status and lipid peroxidation in patients with essential hypertension, J. Hypertens. 16, 1267-1271 (1998).
25. L. M. Klevay, Cardiovascular disease from copper deficiency-a history, J. Nutr. 130(2S Suppl.), 489S-492S (2000).
26. S. K. Taneja, M. Mahajan, S. Gupta, and K. P. Singh, Assessment of copper and zinc status in hair and urine of young women descendants of NIDDM parents, Biol. Trace Element Res. 62, 255-264 (1998).
27. O. Jung, S. L. Marklund, H. Geiger, T. Pedrazzini, R. Busse, and R. P. Brandes, Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice, Circ. Res. 93, 622-629 (2003).
28. C. S. Wilcox, Redox regulation of the afferent arteriole and tubuloglomerular feedback, Acta Physiol. Scand. 179, 217-223 (2003).
29. + exchange and other ion-transport systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats: a comparative analysis, J. Hypertens. 7, 781-788 (1989).
30. R. P. Garay, C. Nazaret, J. Diez, et al., Stimulation of K+ fluxes by diuretic drugs in human red cells, Biochem. Pharmacol. 33, 2013-2020 (1984).
31. G. Zerbini, A. Maestroni, D. Breviario, R. Mangili, and G. Casari, Alternative splicing of NHE-1 mediates Na-Li countertransport and associates with activity rate, Diabetes 52, 1511-1518 (2003).
32. L. L. Ng, P. A. Ouinn, F. Baker, and S. J. Carr, Red cell Na+/Li+ countertransport and Na+/H+ exchanger isoforms in human proximal tubules, Kidney Int. 58, 229-235 (2000).
33. G. Zerbini, F. Podesta, G. Meregalli, G. Deferrari, and R. Pontremoli, Fibroblast Na+-Li+ countertransport rate is elevated in essential hypertension, J. Hypertens. 19, 1263-1269 (2001).
34. A. A. McDonough, P. K. Leong, and L. E. Yang, Mechanisms of pressure natriuresis: how blood pressure regulates renal sodium transport, Ann. NY Acad. Sci. 986, 669-677 (2003).
35. J. Bober, E. Kwiatkowska, K. Ciechanowski, et al., Do trace elements modify the activity of erythrocyte sodium-proton exchanger in hemodialyzed patients? Biol. Trace Element Res., 104, 107-120 (2005).
36. D. A. Clopton and P. Saltman, Copper-specific damage in human erythrocytes exposed to oxidative stress, Biol. Trace Element Res. 56, 231-240 (1997).